Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,078 | 16,122 | 23,488 | 31,831 | 41,671 |
| TOTAL | $12,885 | $17,094 | $24,280 | $32,610 | $42,746 |
| Non-Current Assets | |||||
| PPE Net | 194 | 159 | 186 | 210 | 131 |
| Intangibles | 7,647 | 7,647 | 7,647 | 7,647 | 7,647 |
| Other Non-Current Assets | 739 | 642 | 688 | 549 | 139 |
| TOTAL | $8,581 | $8,448 | $8,521 | $8,406 | $7,917 |
| Total Assets | $21,466 | $25,542 | $32,801 | $41,017 | $50,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 561 | 30 | 1,539 | 61 | 1,034 |
| Accrued Expenses | 1,944 | 2,155 | 3,172 | 2,759 | 4,546 |
| Other current liabilities | 263 | 228 | 226 | 165 | N/A |
| TOTAL | $2,769 | $2,412 | $4,937 | $2,985 | $5,580 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 326 | 264 | 312 | 245 | 0 |
| TOTAL | $326 | $264 | $312 | $245 | $N/A |
| Total Liabilities | $3,095 | $2,677 | $5,249 | $3,230 | $5,580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,095 | 10,095 | 10,095 | 10,087 | 10,087 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -76,251 | -71,094 | -65,843 | -54,801 | -46,833 |
| TOTAL | $18,370 | $22,865 | $27,553 | $37,786 | $45,083 |
| Total Liabilities And Equity | $21,466 | $25,542 | $32,801 | $41,017 | $50,664 |